Wall Street Zen cut shares of Agape ATP (NASDAQ:ATPC – Free Report) from a hold rating to a sell rating in a research note published on Saturday morning.
Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Agape ATP in a research report on Wednesday, January 21st. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock currently has an average rating of “Sell”.
Get Our Latest Analysis on Agape ATP
Agape ATP Stock Up 0.6%
Institutional Inflows and Outflows
An institutional investor recently raised its position in Agape ATP stock. Citadel Advisors LLC increased its holdings in Agape ATP Corporation (NASDAQ:ATPC – Free Report) by 95.7% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 65,130 shares of the company’s stock after purchasing an additional 31,849 shares during the period. Citadel Advisors LLC owned 0.13% of Agape ATP worth $82,000 as of its most recent SEC filing. 0.01% of the stock is owned by institutional investors and hedge funds.
Agape ATP Company Profile
Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement.
Further Reading
Receive News & Ratings for Agape ATP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agape ATP and related companies with MarketBeat.com's FREE daily email newsletter.
